中文 | English
Return
Total: 142 , 1/15
Show Home Prev Next End page: GO
MeSH:( Capecitabine)

5.Hand-foot Syndrome Due to Capecitabine.

Chong Won CHOI ; Chang Hun HUH

Korean Journal of Dermatology 2005;43(7):965-968

6.XELOX ± Bevacizumab compared to FOLFOX4 ± Bevacizumab in first line metastatic colorectal cancer in a non-reimbursed health care system: A cost analysis.

Tan Jerry Y. ; Yacat Andrew A ; Sacdalan Dennis L.

Acta Medica Philippina 2015;49(2):64-67

7.A Phase II Study of Additional Four-Week Chemotherapy With Capecitabine During the Resting Periods After Six-Week Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.

Kyung Ha LEE ; Min Sang SONG ; Jun Boem PARK ; Jin Soo KIM ; Dae Young KANG ; Ji Yeon KIM

Annals of Coloproctology 2013;29(5):192-197

8.A Phase II Study of Additional Four-Week Chemotherapy With Capecitabine During the Resting Periods After Six-Week Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.

Kyung Ha LEE ; Min Sang SONG ; Jun Boem PARK ; Jin Soo KIM ; Dae Young KANG ; Ji Yeon KIM

Annals of Coloproctology 2013;29(5):192-197

9.Histoculture Drug Response Assay in Colorectal Cancer Specimen.

Woo Seok KIM ; Ryung Ah LEE ; Dae Yong HWANG ; Young Joon HONG ; Seok Il HONG

Journal of the Korean Surgical Society 2004;66(2):109-115

10.Prospective Phase II Study of Preoperative Chemoradiation with Capecitabine in Locally Advanced Rectal Cancer.

Jin hong PARK ; Jong Hoon KIM ; Seung Do AHN ; Sang wook LEE ; Seong Soo SHIN ; Jin Cheon KIM ; Chang Sik YU ; Hee Cheol KIM ; Yoon Koo KANG ; Tae Won KIM ; Heung Moon CHANG ; Min Hee RYU ; Eun Kyung CHOI

Cancer Research and Treatment 2004;36(6):354-359

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 142 , 1/15 Show Home Prev Next End page: GO